| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cabozantinib plus Nivolumab: A Review in Advanced Renal Cell Carcinoma
|
Markham, Anthony
|
|
|
17 |
2 |
p. 193-201
|
article
|
| 2 |
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers
|
Takeda, Hiroyuki
|
|
|
17 |
2 |
p. 177-185
|
article
|
| 3 |
Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors
|
Patnaik, Amita
|
|
|
17 |
2 |
p. 139
|
article
|
| 4 |
Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer
|
Fan, Ping
|
|
|
17 |
2 |
p. 111-124
|
article
|
| 5 |
Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP)
|
Le, Dat
|
|
|
17 |
2 |
p. 167-175
|
article
|
| 6 |
Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung Cancer
|
Abu Rous, Fawzi
|
|
|
17 |
2 |
p. 187-192
|
article
|
| 7 |
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
|
Lee, Matilda Xinwei
|
|
|
17 |
2 |
p. 141-151
|
article
|
| 8 |
Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors
|
Patnaik, Amita
|
|
|
17 |
2 |
p. 125-138
|
article
|
| 9 |
Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis
|
Van Sanden, Suzy
|
|
|
17 |
2 |
p. 153-166
|
article
|
| 10 |
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours
|
Foo, Tiffany
|
|
|
17 |
2 |
p. 95-110
|
article
|
Journal description